NOF has strong position for supplying methoxypoly(ethylene glycol) (mPEG) and their derivatives for pharmaceutical and drug developments in the global market.
Our advantageous capability of providing mPEG-OHs (Patent No. USP 6455639, EP0985697, JP3050228, KR0358276) as following;
1) our proprietary high purity mPEG-OHs
2) our proprietary superior manufacturing methods of activated PEGs made from high purity mPEG-OHs
We produce the world's best quality Activated PEGs from our high-quality mPEGs. We also offer our proprietary branched activated PEGs, high-purity multi-arm PEGs and their activated derivatives, heterofunctional PEGs, and activated PEGs tailored to meet our customers' needs. NOF can supply activated PEGs produced to current good manufacturing practice (cGMP) standards in our state-of-the-art GMP facility. NOF can help you to modify your drugs by using our PEGylation technology and our high-quality activated PEGs.